159 related articles for article (PubMed ID: 5665982)
1. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
[No Abstract] [Full Text] [Related]
2. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
Young RC; DeVita VT
Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
[No Abstract] [Full Text] [Related]
3. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Tyrer DD; Kline I; Venditti JM; Goldin A
Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
Pazdernik TL; Uyeki EM
J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
[TBL] [Abstract][Full Text] [Related]
5. Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).
Bonmassar E; Cudkowicz G; Vadlamudi S; Goldin A
Cancer Res; 1970 Oct; 30(10):2538-42. PubMed ID: 5474176
[No Abstract] [Full Text] [Related]
6. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
Tsukagoshi S; Kao MH; Goldin A
Cancer Chemother Rep; 1968 Sep; 52(5):569-78. PubMed ID: 5743704
[No Abstract] [Full Text] [Related]
7. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
Venditti JM; Kline I; Tyrer DD; Goldin A
Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
[No Abstract] [Full Text] [Related]
8. Criteria associated with destruction of leukemia and solid tumor cells in animals.
Skipper HE
Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
[No Abstract] [Full Text] [Related]
9. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
Cohen MH
J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
[No Abstract] [Full Text] [Related]
10. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
Shapiro WR; Ausman JI; Rall DP
Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
[No Abstract] [Full Text] [Related]
11. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug.
Bonmassar E; Bonmassar A; Vadlamudi S; Goldin A
Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1089-95. PubMed ID: 5273445
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.
Cohen MH; Carbone PP
J Natl Cancer Inst; 1972 Apr; 48(4):921-6. PubMed ID: 5023689
[No Abstract] [Full Text] [Related]
13. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
[No Abstract] [Full Text] [Related]
14. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
15. The effects of chemotherapy on the kinetics of leukemic cell behavior.
Skipper HE
Cancer Res; 1965 Oct; 25(9):1544-50. PubMed ID: 5861078
[No Abstract] [Full Text] [Related]
16. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.
Vadlamudi S; Choudry JN; Waravdekar VS; Kline I; Goldin A
Cancer Res; 1970 Feb; 30(2):362-9. PubMed ID: 5458970
[No Abstract] [Full Text] [Related]
17. Structure-activity relationships: nitrosoureas.
Johnston TP
Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
[No Abstract] [Full Text] [Related]
18. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
Shapiro WR
J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
[No Abstract] [Full Text] [Related]
19. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
[No Abstract] [Full Text] [Related]
20. Effect of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on hematopoietic precursors in the mouse.
Preisler HD; Henderson ES
J Natl Cancer Inst; 1971 Nov; 47(5):971-7. PubMed ID: 5123339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
